GlassScriptPhysician profile
Bethany Desroches
NPI 1982015020
$32,161.58
in general payments reported to CMS, 2019-2025
11 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $795 · 2021: $88.16 · 2022: $123 · 2023: $322 · 2024: $471 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,615.76 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Intuitive Surgical, INC. | $794.54 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.65 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $153.91 | 2023-2025 | Orgovyx |
| Baxter Healthcare | $142.48 | 2024 | |
| Koelis INC. | $90.00 | 2025 | |
| Civco Medical Instruments | $72.93 | 2024 | |
| Kerecis Limited | $45.29 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Laborie Medical Technologies Corp. | $43.58 | 2022 | |
| Myovant Sciences INC. | $25.71 | 2022 | |
| Ambu INC. | $17.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Desroches listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.